2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media.
Click HERE To See Why Big Tech Is Hoarding Gas
Karen A. Foster, insider at BioLife Solutions
Karen A. Foster Insider Alerts

Get notified the next time Karen A. Foster buys or sells BioLife Solutions stock. Enter your email address below to get our daily insider buying and selling report.

Karen A. Foster Insider Information

Insider of BioLife Solutions
Karen Foster has been chief quality officer at BioLife since December 2019. She joined the company as Vice President of Operations in April 2016. From 2003 to early 2016, Karen was Vice President of Laboratory Operations and Site Leader at ViaCord, LLC, a family cord blood bank, and subsidiary of PerkinElmer Inc.

Karen has managed manufacturing and quality operations in several capacities over the course of her 25-year career, for such companies as Pfizer, Inc. (formerly Pharmacia Corporation) and Amersham Pharmacia Biotech, Inc. (formerly Pharmacia Biotech, Inc.)

She has two degrees from the University of Wisconsin, Milwaukee:  an MBA specializing in Operations Management, and an MS in Zoology. She earned her B.S. in Biological Sciences from Michigan Technological University.

What is Karen A. Foster's net worth?

The estimated net worth of Karen A. Foster is at least $3.51 million as of June 21st, 2021. Ms. Foster owns 89,716 shares of BioLife Solutions stock worth more than $3,506,998 as of November 30th. This net worth approximation does not reflect any other assets that Ms. Foster may own. Learn More.

What is Karen A. Foster's salary?

As the Insider of BioLife Solutions, Inc., Ms. Foster earned a total compensation package of $887,078.00 in 2020. Ms. Foster earned a salary of $345,731.00, stock awards of $541,347.00, and no other miscellaneous compensation.

How do I contact Karen A. Foster?

The corporate mailing address for Ms. Foster and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]

Has Karen A. Foster been buying or selling shares of BioLife Solutions?

In the last ninety days, Karen A. Foster has sold $1,523,580.00 in BioLife Solutions stock. Most recently, Karen A. Foster sold 16,332 shares of the business's stock in a transaction on Monday, November 22nd. The shares were sold at an average price of $46.19, for a transaction totalling $754,375.08.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), and Marcus Schulz (CRO).

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, insiders at the medical equipment provider sold shares 134 times. They sold a total of 1,245,867 shares worth more than $47,751,638.43. The most recent insider tranaction occured on November, 22nd when insider Karen A Foster sold 16,332 shares worth more than $754,375.08. Insiders at BioLife Solutions own 5.9 % of the company.

Information on this page was last updated on 11/22/2021.

Karen A. Foster Insider Trading History at BioLife Solutions

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Sell16,332$46.19$754,375.08View SEC Filing Icon  
10/25/2021Sell16,332$44.45$725,957.40View SEC Filing Icon  
10/14/2021Sell1,082$39.97$43,247.54View SEC Filing Icon  
9/27/2021Sell16,332$44.66$729,387.12View SEC Filing Icon  
8/23/2021Sell16,332$46.54$760,091.28View SEC Filing Icon  
7/26/2021Sell16,333$45.24$738,904.92View SEC Filing Icon  
6/21/2021Sell16,332$42.79$698,846.2889,716View SEC Filing Icon  
5/24/2021Sell16,332$31.44$513,478.0889,980View SEC Filing Icon  
4/19/2021Sell16,332$32.58$532,096.5689,980View SEC Filing Icon  
4/1/2021Sell3,414$36.53$124,713.4274,208View SEC Filing Icon  
3/26/2021Sell2,562$35.01$89,695.6265,411View SEC Filing Icon  
3/22/2021Sell16,332$37.56$613,429.9284,305View SEC Filing Icon  
2/26/2021Sell284$39.57$11,237.8867,973View SEC Filing Icon  
2/22/2021Sell16,334$39.66$647,806.4484,591View SEC Filing Icon  
2/19/2021Sell3,344$40.76$136,301.4454,899View SEC Filing Icon  
2/17/2021Sell3,281$41.55$136,325.5554,899View SEC Filing Icon  
12/1/2020Sell166$35.49$5,891.3450,742View SEC Filing Icon  
9/29/2020Sell977$28.63$27,971.5150,908View SEC Filing Icon  
8/26/2020Sell179$20.48$3,665.9251,885View SEC Filing Icon  
5/28/2020Sell170$16.87$2,867.9052,064View SEC Filing Icon  
2/26/2020Sell884$15.02$13,277.6823,701View SEC Filing Icon  
See Full Table

Karen A. Foster Buying and Selling Activity at BioLife Solutions

This chart shows Karen A Foster's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Read More

Today's Range

Now: $39.09
Low: $38.91
High: $41.55

50 Day Range

MA: $46.71
Low: $37.86
High: $58.55

2 Week Range

Now: $39.09
Low: $28.15
High: $60.67

Volume

421,024 shs

Average Volume

420,010 shs

Market Capitalization

$1.59 billion

P/E Ratio

390.94

Dividend Yield

N/A

Beta

1.56
Health Stock on the Rise
This stock could be a major success story in 2021.
Here's why.